Corrigendum to “Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis”. Molecular Immunology 124 (2020) 161–171 (Molecular Immunology (2020) 124 (161–171), (S0161589020303886), (10.1016/j.molimm.2020.06.010))

João A. Oliveira-da-Silva, Daniela P. Lage, Fernanda F. Ramos, Amanda S. Machado, Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira, Vívian T. Martins, Lívia M. Carvalho, Fernanda Ludolf, Thaís T.O. Santos, Thiago A.R. Reis, Camila S. Freitas, Raquel S. Bandeira, Alessandra M. Silva, Lourena E. Costa, Jamil S. Oliveira, Mariana C. Duarte, Bruno M. Roatt, Antônio L. TeixeiraEduardo A.F. Coelho

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to “Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis”. Molecular Immunology 124 (2020) 161–171 (Molecular Immunology (2020) 124 (161–171), (S0161589020303886), (10.1016/j.molimm.2020.06.010))'. Together they form a unique fingerprint.

Medicine and Dentistry